ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Hematology Oncology

Top Hematology Oncology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT EXTEN MD

Hematology Oncology

4,908

$914K

463
418 are 65+

6%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$186
Average prescription price

Avg: $438

KELLI CAWLEY MD

Hematology Oncology

3,998

$1.3M

437
328 are 65+

23%
patients receiving schedule two controlled substances

Avg: 18%

12%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$325
Average prescription price

Avg: $438

JAMES SCHMOTZER MD

Hematology Oncology

3,426

$998K

329
264 are 65+

17%
patients receiving schedule two controlled substances

Avg: 18%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 18%

$291
Average prescription price

Avg: $438

LORI HEMROCK M.D.

Hematology Oncology

3,185

$1.29M

382
329 are 65+

16%
patients receiving schedule two controlled substances

Avg: 18%

13%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$407
Average prescription price

Avg: $438

JOHN PETRUS MD

Hematology Oncology

3,178

$772K

283
163 are 65+

57%
patients receiving schedule two controlled substances

Avg: 18%

20%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 18%

$243
Average prescription price

Avg: $438

ANTOINE CHAHINE MD

Hematology Oncology

2,767

$1.45M

469
400 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$523
Average prescription price

Avg: $438

NAGAPRASAD NAGAJOTHI M.D.

Hematology Oncology

2,742

$1.07M

351
293 are 65+

12%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$389
Average prescription price

Avg: $438

SHRUTI TREHAN MD

Hematology Oncology

2,720

$939K

335
296 are 65+

11%
patients receiving schedule two controlled substances

Avg: 18%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$345
Average prescription price

Avg: $438

ELYSE LOWER MD

Hematology Oncology

2,626

$281K

335
260 are 65+

10%
patients receiving schedule two controlled substances

Avg: 18%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$107
Average prescription price

Avg: $438

NOMAN RAFIQUE M.D.

Hematology Oncology

2,523

$790K

334
277 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

16%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$313
Average prescription price

Avg: $438

DOUGLAS HAWLEY MD

Hematology Oncology

2,503

$1.09M

232
166 are 65+

28%
patients receiving schedule two controlled substances

Avg: 18%

11%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 18%

$437
Average prescription price

Avg: $438

GANAPATHY KRISHNAN M.D.

Hematology Oncology

2,471

$566K

286
214 are 65+

32%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 18%

$229
Average prescription price

Avg: $438

SHARON COLE M.D.

Hematology Oncology

2,389

$556K

392
348 are 65+

17%
patients receiving schedule two controlled substances

Avg: 18%

9%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 18%

$233
Average prescription price

Avg: $438

CHARLES BANE MD

Hematology Oncology

2,253

$684K

289
247 are 65+

17%
patients receiving schedule two controlled substances

Avg: 18%

18%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 18%

$304
Average prescription price

Avg: $438

HENRY GERAD MD

Hematology Oncology

2,250

$253K

283
240 are 65+

17%
patients receiving schedule two controlled substances

Avg: 18%

16%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 18%

$112
Average prescription price

Avg: $438

SANDRA HAZRA MD

Hematology Oncology

2,224

$790K

259
200 are 65+

16%
patients receiving schedule two controlled substances

Avg: 18%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 18%

$355
Average prescription price

Avg: $438

AMY AWAIDA M.D.

Hematology Oncology

2,170

$1.02M

386
322 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 18%

$472
Average prescription price

Avg: $438

PAULA WEISENBERGER MD

Hematology Oncology

2,135

$885K

332
265 are 65+

27%
patients receiving schedule two controlled substances

Avg: 18%

10%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 18%

$415
Average prescription price

Avg: $438

DAVID POWELL DO

Hematology Oncology

2,134

$718K

319
267 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

12%
patients receiving schedule three controlled substances

Avg: 8%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 18%

$336
Average prescription price

Avg: $438

CHRIS KNIGHT M.D.

Hematology Oncology

2,106

$695K

338
294 are 65+

18%
patients receiving schedule two controlled substances

Avg: 18%

17%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 18%

$330
Average prescription price

Avg: $438

JUDAH FRIEDMAN M.D.

Hematology Oncology

2,049

$813K

219
186 are 65+

21%
patients receiving schedule two controlled substances

Avg: 18%

10%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 18%

$397
Average prescription price

Avg: $438

KURT LEUENBERGER MD

Hematology Oncology

1,941

$619K

259
203 are 65+

21%
patients receiving schedule two controlled substances

Avg: 18%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 18%

$319
Average prescription price

Avg: $438

MARY GAEKE MD

Hematology Oncology

1,867

$190K

160
130 are 65+

18%
patients receiving schedule two controlled substances

Avg: 18%

26%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 18%

$102
Average prescription price

Avg: $438

ESTHER REHMUS M.D.

Hematology Oncology

1,842

$595K

265
216 are 65+

20%
patients receiving schedule two controlled substances

Avg: 18%

12%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 18%

$323
Average prescription price

Avg: $438

EDWARD CRANE MD

Hematology Oncology

1,819

$267K

231
187 are 65+

29%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 18%

$147
Average prescription price

Avg: $438

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank